Transcode Therapeutics, Inc.
RNAZ
Revenue
0.00
0.000.00%
-Assets
4.82M
▼-2.47M▼-33.82%
3 Months ChangeLiabilities
3.50M
▲796.14k▲29.42%
3 Months ChangeFree Cash Flow
-3.94M
▲585.38k▲12.93%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0001104659-24-103706
2024-08-28
Form 8-K
ID: 0001104659-24-093614
2024-08-16
Form 8-K
ID: 0001104659-24-090559
2024-08-14
Form 10-Q
ID: 0001558370-24-012264
2024-07-24
Form 8-K
ID: 0001104659-24-082155
2024-06-13
Form 8-K
ID: 0001104659-24-071337
2024-06-07
Form 8-K
ID: 0001104659-24-069605
2024-05-15
Form 8-K
ID: 0001104659-24-062047
2024-05-15
Form 10-Q
ID: 0001558370-24-008298
2024-05-10
Form 8-K
ID: 0001104659-24-059963